Mineralys Therapeutics Ratios (2022-2026) | MLYS

Ratios Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter) 210.44M298.83M284.39M264.60M299.44M332.87M293.37M237.08M280.42M345.33M467.84M630.88M657.33M
Equity Average (Quarter) -33.70M-40.17M-47.84M121.80M290.44M274.51M252.58M284.60M309.07M263.51M214.09M266.41M327.55M444.99M611.56M642.42M
Invested Capital (Quarter) -30.48M-36.93M-43.41M-52.27M295.88M285.01M264.01M241.15M328.05M290.10M236.93M191.26M341.56M313.55M576.43M646.69M638.14M
Leverage & Solvency
Equity Ratio (Quarter) -0.460.970.980.950.960.940.910.880.930.960.930.960.980.98
Valuation
Enterprise Value (Quarter) -107.24M-270.64M-261.10M-253.76M-236.57M-333.19M-311.12M-263.60M-198.19M-343.01M-323.88M-592.38M-655.61M-644.93M
Return Ratios
Return on Capital Employed (Quarter) -19.44%-16.44%-24.72%-33.31%-37.50%-44.18%-64.24%-86.50%-75.45%-62.84%-41.43%-27.71%-26.69%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%0.00%0.00%0.00%
Return on Equity (Quarter) 0.01%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%0.00%0.00%0.00%